Disease Info Card

Ataxia Telangiectasia

Information about Ataxia Telangiectasia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Ataxia Telangiectasia

Most recent studies have shown that Ataxia Telangiectasia shares some biological mechanisms with agammaglobulinemia, anemia, ataxia, carcinoma, cell-transformation-neoplastic, chromosome-breakage, cytogenetic-abnormality, fanconi-anemia, genomic-instability, hereditary-diseases, immunologic-deficiency-syndromes, leukemia, lymphoma, malignant-neoplasm-of-breast, malignant-neoplasms, mammary-neoplasms, neoplasms, nijmegen-breakage-syndrome, telangiectasis, xeroderma-pigmentosum.

Among the many pathways, these few ones have gauged particular interests from scientists studying Ataxia Telangiectasia, and have been seen in publications frequently: Aging, Cell Cycle, Cell Cycle Arrest, Cell Cycle Checkpoint, Cell Death, Cell Growth, Cell Killing, Cell Proliferation, Chromosome Breakage, Dna Damage Checkpoint, Dna Repair, Dna Replication, G2 Phase, Hypersensitivity, Localization, Mitosis, Pathogenesis, Response To Ionizing Radiation, S Phase, Senescence

Quite a number of genes have been found to play important roles in Ataxia Telangiectasia, such as ANTXR1, ARTN, ATM, ATR, BRCA1, CDKN1A, CDKN2A, CHEK1, CHEK2, MMAB, NBN, NLRP2, NSG1, PRKDC, RAD50, TCEAL1, TP53, TP53BP1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.